BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Manolis TA, Manolis AA, Manolis AS. Cardiovascular Safety of Psychiatric Agents: A Cautionary Tale. Angiology 2019;70:103-29. [PMID: 29874922 DOI: 10.1177/0003319718780145] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 2.3] [Reference Citation Analysis]
Number Citing Articles
1 Katsiki N, Mikhailidis DP, Papanas N. Depression in cardiac and non-cardiac vascular diseases: Current evidence and future perspectives. International Journal of Cardiology 2018;271:21-2. [DOI: 10.1016/j.ijcard.2018.07.055] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
2 Chua AL, Mehla S, Orlova YY. Drug Safety in Episodic Migraine Management in Adults. Part 2: Preventive Treatments. Curr Pain Headache Rep 2022. [PMID: 35587859 DOI: 10.1007/s11916-022-01051-9] [Reference Citation Analysis]
3 Sattler SM, Lubberding AF, Kristensen CB, Møgelvang R, Blanche P, Fink-Jensen A, Engstrøm T, Kääb S, Jespersen T, Tfelt-Hansen J. Effect of the antipsychotic drug haloperidol on arrhythmias during acute myocardial infarction in a porcine model. Int J Cardiol Heart Vasc 2020;26:100455. [PMID: 32140549 DOI: 10.1016/j.ijcha.2019.100455] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Mazereel V, Detraux J, Vancampfort D, van Winkel R, De Hert M. Impact of Psychotropic Medication Effects on Obesity and the Metabolic Syndrome in People With Serious Mental Illness. Front Endocrinol (Lausanne) 2020;11:573479. [PMID: 33162935 DOI: 10.3389/fendo.2020.573479] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
5 Cao H, Zhou Y, Li T, Yao C, Yang W, Kong S, Wang Y, Yu B, Jiao Q, Sun Y, Jia X, Wang Y, Wang Z, Zhang X, Li J. The Prevalence, Risk Factors and Clinical Correlates of QTc Prolongation in Chinese Hospitalized Patients With Chronic Schizophrenia. Front Psychiatry 2021;12:704045. [PMID: 34483996 DOI: 10.3389/fpsyt.2021.704045] [Reference Citation Analysis]
6 Pejčić AV, Janković SM, Davidović G. Drug-drug interactions in patients with acute coronary syndrome across phases of treatment. Intern Emerg Med 2019;14:411-22. [PMID: 30483990 DOI: 10.1007/s11739-018-1994-8] [Cited by in Crossref: 3] [Article Influence: 0.8] [Reference Citation Analysis]
7 Seppi K, Ray Chaudhuri K, Coelho M, Fox SH, Katzenschlager R, Perez Lloret S, Weintraub D, Sampaio C; the collaborators of the Parkinson's Disease Update on Non-Motor Symptoms Study Group on behalf of the Movement Disorders Society Evidence-Based Medicine Committee. Update on treatments for nonmotor symptoms of Parkinson's disease-an evidence-based medicine review. Mov Disord 2019;34:180-98. [PMID: 30653247 DOI: 10.1002/mds.27602] [Cited by in Crossref: 258] [Cited by in F6Publishing: 201] [Article Influence: 86.0] [Reference Citation Analysis]
8 Qayyum Z, Zablan K, Zeshan M, Kalaskar S, Malik S. Cardiovascular Side Effects of Psychotropic Agents. Psychiatric Annals 2021;51:416-20. [DOI: 10.3928/00485713-20210809-02] [Reference Citation Analysis]